期刊文献+

海洋天然活性产物Fascap lysin的研究进展

Advances in Research on Marine Bioactive Compound Fascaplysin
原文传递
导出
摘要 Fascap lysin是从海绵中发现的一种海洋天然活性产物,具有抗肿瘤、抗细菌、抗真菌、抗病毒、抗疟疾、抑制胆碱酯酶等多种生物活性。近年来,Fascaplysin被发现能选择性抑制抗肿瘤靶标——细胞周期蛋白依赖性激酶4,因而备受关注。综述Fascaplysin的抗肿瘤机制、全合成及结构改造的研究进展。 Fascaplysin, a marine active product discoverd from sponge, shows various bioactivities including antitumor, antimicrobial, antifungal, antiviral, antimalarial, cholinesterase inhibitory effects, etc. Recently, it has been found that Fascaplysin possesses a specific inhibitory effect on cyclin dependent kinase 4(CDK4) to be a promising antitumor target which can promote tumor cell proliferation. Theretbre, Fascaplysin has drawn a wide academic attention. The advances in research on the antitumor mechanism, total synthesis and structural modification of Fascaplysin were reviewed.
出处 《药学进展》 CAS 2014年第5期340-348,共9页 Progress in Pharmaceutical Sciences
关键词 Fascaplysin 细胞周期蛋白依赖性激酶4抑制剂 抗肿瘤机制 全合成 结构改造 Fascaplysin CDK4 inhibitor antitumor mechanism total synthesis structural modification
  • 相关文献

参考文献4

二级参考文献104

  • 1Alvarez-Salas LM, DiPaolo JA. Molecular approaches to cervical cancer therapy [J]. Curr Drug Discov Technol, 2007, 4: 208-219.
  • 2Schwartsmann G, Ratain M J, Cragg GM, et al. Anticancer drug discovery and development throughout the world [J]. J Clin Oncol, 2002, 20: 47S-59S.
  • 3Roll DM, Ireland CM, Lu HSM, et al. Fascaplysin, an unusual antimicrobial pigment from the marine sponge Fascaplysinopsis sp [J]. J Org Chem, 1988, 53: 3276- 3278.
  • 4Segraves NL, Lopez S, Johnson TA, et al. Structures and cytotoxicities of fascaplysin and related alkaloids from two marine phyla--Fascaplysinopsis sponges and Didemnum tunicates [J]. Tetrahedron Lett, 2003, 44: 3471-3475.
  • 5Soni R, Muller L, Furet P, et al. Inhibition of cyclindependent kinase 4 (Cdk4) by fascaplysin, a marine natural product [J]. Biochem Biopbys Res Commun, 2000, 275: 877-884.
  • 6Lin J, Yan X J, Chen HM. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo [J]. Cancer Chemother Pharmacol, 2007, 59: 439-445.
  • 7Subramanian B, Nakeff A, Tenney K, et al. A new paradigm for the development of anticancer agents from natural products [J]. J lExp Ther Oncol, 2006, 5: 195-204.
  • 8Calbo J, Serna C, Garriga J, et al. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity [J]. Cell Death Differ, 2004, 11 1055-1065.
  • 9Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control [J]. J Clin Invest, 1999, 104: 1645-1653.
  • 10Jiang H, Chou HS, Zhu L. Requirement of cyclin E-Cdk2 inhibition in p16 (INK4a)-mediated growth suppression [J]. Mol Cell Biol, 1998, 18: 5284-5290.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部